台股 » 個股 » 共信-KY » 籌碼相關 » 券商分點績效 » 券商分點個股進出

共信-KY

(6617)
  • 股價
    108.0
  • 漲跌
    ▲5.0
  • 漲幅
    +4.85%
  • 成交量
    111
  • 產業
    上櫃 生技醫療類股
  • 41人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
共信-KY (6617)籌碼相關-群益金鼎-高雄 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

群益金鼎-高雄 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/11/1800.003107.00103.00-3243-1.23%
2024/11/084120.0000.00115.0042681.49%
2024/10/0900.001111.50113.00-1324-0.31%
2024/09/260.1119.0000.00117.500.13580.03%
2024/09/241118.508119.19119.50-7365-1.91%
2024/09/1200.002128.25124.50-2524-0.38%
2024/09/112126.7500.00128.0025660.35%
2024/09/101123.5000.00120.0015630.18%
2024/08/301131.0000.00129.5015500.18%
2024/08/291131.5000.00131.5015510.18%
2024/08/282133.501132.50133.5015650.18%
2024/08/2600.0011124.73125.50-11555-1.98%
2024/08/2311129.5500.00126.00115521.99%
2024/08/221126.000.3126.27129.000.75430.12%
2024/08/190100.0000.00103.0005100.00%
2024/08/150.598.0000.0098.500.55020.10%
2024/08/141.199.7900.0096.501.14990.21%
2024/08/130101.5000.00101.0004910.01%
2024/08/120101.5800.00101.5004920.00%
2024/08/080103.4000.00102.5004870.01%
2024/08/061102.000.1110.50103.500.94710.19%
2024/08/052112.0000.00112.0024640.43%
2024/08/020.2127.7400.00124.000.24610.05%
2024/07/290.4134.1300.00130.000.44520.08%
2024/07/260.4139.1300.00136.000.44480.09%
2024/07/230.2137.5000.00140.500.24450.04%
2024/07/170.1135.5000.00136.000.14180.01%
2024/07/160.1138.0000.00136.000.14160.02%
2024/07/151133.5000.00132.5014130.24%
2024/07/120136.5000.00135.0004100.01%
2024/07/101135.0000.00135.0014080.24%
2024/07/084137.2500.00135.0044090.98%
2024/07/021141.0000.00137.5013830.26%
2024/06/283147.0000.00147.0033730.80%
2024/06/265151.5000.00153.0053571.40%
2024/06/256144.3300.00147.5063421.75%
2024/06/241146.502150.50147.00-1329-0.30%
2024/06/211154.0015.1159.48160.00-14.1300-4.69%
2024/06/206139.832144.75146.5042531.58%
2024/06/1900.003131.83128.50-3214-1.40%
2024/06/188.3133.0010133.75132.00-1.7199-0.86%
〈熱門股〉共信-KY旗下PTS進軍寵物市場 跌深反彈周漲逾2成Anue鉅亨-2024/08/24
共信-KY動物抗癌新藥申請台灣藥證 明年H2有望取得藥證Anue鉅亨-2024/07/31
共信-KY 相關文章
共信-KY 相關影音